Neuroscience
FromThe New York Times:
Tests Show Promise for Early Diagnosis of Alzheimer’s
By GINA KOLATA
The New York Times
Published: January 18, 2011
"Researchers report major advances on two vexing questions about Alzheimer’s: How do you know if someone who is demented has it? And how can you screen the general population for risk?"
Read the full article.
The report includes discussion about this week's forthcoming FDA Advisory Committee discussion about Avid Radiopharmaceuticals product.
- Alzheimer's Disease
In Preventing Alzheimer’s, Mutation May Aid Drug Quest The New York Times By GINA KOLATA 11 July 2012 [snip] Two decades ago, researchers began discovering rare gene mutations that cause Alzheimer’s disease in all who inherit them. Now, they have...
- Alzheimer's Disease: "how Do You Live Knowing You Might Have An Alzheimer’s Gene?"
How Do You Live Knowing You Might Have an Alzheimer’s Gene? By GINA KOLATA The New York Times 07 June 2012 Read the full article...
- Dilemma Of Ever Earlier Diagnosis Of Alzheimer's Disease
Gina Kolata has written a fine piece inThe New York Times: Early Tests for Alzheimer’s Pose Diagnosis Dilemma By GINA KOLATA The New York Times Published: December 17, 2010 "Since there is no treatment, doctors wonder if they should tell people, years...
- Alzheimer's Disease: Rethinking Things?
A very readable piece from Gina Kolata of the New York Times: Doubt on Tactic in Alzheimer’s Battle By GINA KOLATA The New York Times Published: August 18, 2010 "The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and...
- Alzheimer's Disease: A-beta And Immune System
Old Enemy Might Help to Prevent Alzheimer’s By GINA KOLATA The New York Times Published: March 8, 2010 "Harvard researchers are taking a new look at beta amyloid, which was thought to be a chief villain in Alzheimer’s whose function was that of a...
Neuroscience
Alzheimer's Products
FromThe New York Times:
Tests Show Promise for Early Diagnosis of Alzheimer’s
By GINA KOLATA
The New York Times
Published: January 18, 2011
"Researchers report major advances on two vexing questions about Alzheimer’s: How do you know if someone who is demented has it? And how can you screen the general population for risk?"
Read the full article.
The report includes discussion about this week's forthcoming FDA Advisory Committee discussion about Avid Radiopharmaceuticals product.
- Alzheimer's Disease
In Preventing Alzheimer’s, Mutation May Aid Drug Quest The New York Times By GINA KOLATA 11 July 2012 [snip] Two decades ago, researchers began discovering rare gene mutations that cause Alzheimer’s disease in all who inherit them. Now, they have...
- Alzheimer's Disease: "how Do You Live Knowing You Might Have An Alzheimer’s Gene?"
How Do You Live Knowing You Might Have an Alzheimer’s Gene? By GINA KOLATA The New York Times 07 June 2012 Read the full article...
- Dilemma Of Ever Earlier Diagnosis Of Alzheimer's Disease
Gina Kolata has written a fine piece inThe New York Times: Early Tests for Alzheimer’s Pose Diagnosis Dilemma By GINA KOLATA The New York Times Published: December 17, 2010 "Since there is no treatment, doctors wonder if they should tell people, years...
- Alzheimer's Disease: Rethinking Things?
A very readable piece from Gina Kolata of the New York Times: Doubt on Tactic in Alzheimer’s Battle By GINA KOLATA The New York Times Published: August 18, 2010 "The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and...
- Alzheimer's Disease: A-beta And Immune System
Old Enemy Might Help to Prevent Alzheimer’s By GINA KOLATA The New York Times Published: March 8, 2010 "Harvard researchers are taking a new look at beta amyloid, which was thought to be a chief villain in Alzheimer’s whose function was that of a...